Antisense Therapeutics Ltd
OTC:ATHJF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Antisense Therapeutics Ltd
OTC:ATHJF
|
AU |
|
Transakt Ltd
OTC:TAKD
|
HK |
|
N
|
North-Star International Co Ltd
TPEX:8927
|
TW |
|
Aadi Bioscience Inc
NASDAQ:WHWK
|
US |
|
W
|
Wonik Holdings Co Ltd
KOSDAQ:030530
|
KR |
|
P
|
Pyramid Games SA
WSE:PDG
|
PL |
|
H
|
Huadian Power International Corp Ltd
OTC:HPIFF
|
CN |
|
Treatt PLC
OTC:TTTRF
|
UK |
|
High Country Bancorp Inc
OTC:HCBC
|
US |
|
Benton Resources Inc
F:LH9
|
CA |
|
Starhill Global Real Estate Investment Trust
SGX:P40U
|
SG |
|
T
|
Tribe Technology PLC
LSE:TRYB
|
UK |
|
F
|
Foreign Trade Bank of Latin America Inc
SWB:D8Q
|
PA |
|
M
|
Mikron Holding AG
XMUN:MH4N
|
CH |
|
V
|
Vedant Asset Ltd
BSE:543623
|
IN |
Bankruptcy Probability
Antisense Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Antisense Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Antisense Therapeutics Ltd
ASX:ANP
|
75.7m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
640.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
364.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
248.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
251.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Antisense Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Antisense Therapeutics Ltd has total debt of 48k AUD. This includes both short-term (0 AUD) and long-term (48k AUD) debt.
You can find a full breakdown on its Balance Sheet.
